RecurrenceSalvage TherapyTreatment OutcomeRemission InductionAntineoplastic Combined Chemotherapy ProtocolsHodgkin DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationCytarabineCyclophosphamideAntibodies, Monoclonal, Murine-DerivedLymphoma, Non-HodgkinEtoposideTransplantation, HomologousCombined Modality TherapyThiotepaTransplantation ConditioningDrug Resistance, NeoplasmMelphalanMultiple MyelomaDisease-Free SurvivalVincristineAntineoplastic AgentsPrognosisAntibodies, MonoclonalNeoplasm Recurrence, LocalSurvival RatePrednisoneBone Marrow TransplantationLymphoma, FollicularSurvival AnalysisAnemia, RefractoryDrug Administration ScheduleMethotrexateRetrospective StudiesRefractory Period, ElectrophysiologicalLeukemia, Myeloid, AcuteGraft vs Host DiseaseLymphoma, Large B-Cell, DiffuseImmunosuppressive AgentsFollow-Up StudiesStem Cell TransplantationDrug ResistanceDoxorubicinTime FactorsClinical Trials as TopicAnemia, Refractory, with Excess of BlastsDisease ProgressionPrecursor Cell Lymphoblastic Leukemia-LymphomaTreatment FailureNeoplasm, ResidualDrug Therapy, CombinationProspective StudiesInfusions, IntravenousThalidomideDose-Response Relationship, DrugLeukemiaAnticonvulsantsAcute DiseaseBoronic AcidsPyrazinesMyelodysplastic SyndromesBehavior, AddictiveVidarabineBone MarrowDrug EvaluationLeukemia, MyeloidEpilepsyLeukemic InfiltrationTesticular NeoplasmsAsparaginaseRefractory Period, PsychologicalMitoxantroneImmunologic FactorsIdarubicinArabinonucleosidesMaximum Tolerated DosePrednisoloneNeoplasm StagingAdministration, OralRetreatmentLeukemia, LymphoidMethylprednisoloneHematologic NeoplasmsAnemia, SideroblasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCentral Nervous System NeoplasmsKaplan-Meier EstimateMultiple Sclerosis, Relapsing-RemittingRisk FactorsDexamethasonePain, IntractableWegener GranulomatosisNeoplasmsIfosfamideChronic DiseaseSelf AdministrationCocaine-Related DisordersCarmustineActuarial Analysis